This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Feb;55(2):213-6.

doi: 10.1053/j.ajkd.2009.12.003.

Why do patients develop proteinuria with sirolimus? Do we have the answer?

Jeremy R Chapman, Gopala K Rangan

PMID: 20116681
DOI: 10.1053/j.ajkd.2009.12.003

Editorial

Why do patients develop proteinuria with sirolimus? Do we have the answer?

Jeremy R Chapman et al. Am J Kidney Dis. 2010 Feb.

. 2010 Feb;55(2):213-6.

doi: 10.1053/j.ajkd.2009.12.003.

Authors

Jeremy R Chapman, Gopala K Rangan

PMID: 20116681
DOI: 10.1053/j.ajkd.2009.12.003

No abstract available

PubMed Disclaimer

Comment on

Tubular toxicity in sirolimus- and cyclosporine-based transplant immunosuppression strategies: an ancillary study from a randomized controlled trial.
Franz S, Regeniter A, Hopfer H, Mihatsch M, Dickenmann M. Franz S, et al. Am J Kidney Dis. 2010 Feb;55(2):335-43. doi: 10.1053/j.ajkd.2009.09.004. Epub 2009 Nov 17. Am J Kidney Dis. 2010. PMID: 19926370 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science